Hirano Kazuhiko, Uno Kaname, Kuwabara Haruki, Kojima Kaoruko, Ohno Shin-Ichiro, Sakurai Hiroyuki, Kamma Hiroshi, Kurata Atsushi
Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan.
Kyorin University School of Medicine, Tokyo, Japan.
Pathol Res Pract. 2014 Oct;210(10):634-9. doi: 10.1016/j.prp.2014.05.001. Epub 2014 May 16.
L-type amino acid transporter 1 (LAT1) is a Na(+)-independent neutral amino acid transporter that has an essential role in cell proliferation. Although the involvement of LAT1 in human carcinogenesis has been investigated by immunohistochemistry in various organs, LAT1 expression in skin has not been reported yet. Therefore, in the present study, immunohistochemistry for LAT1 was performed in 15 keratoacanthoma (KA), 10 seborrheic keratosis, 16 Bowen's disease, 11 basal cell carcinoma (BCC), and 9 squamous cell carcinoma (SCC) cases as well as 61 normal epidermis as control. It was demonstrated that LAT1 expression limited to the basal layer was occasionally observed in normal epidermis while its expression was significantly decreased in the epithelium of seborrheic keratosis and Bowen's disease (P<0.05). By contrast, a significantly higher rate of LAT1 expression was observed in the epithelium of KA, BCC, and SCC than in normal epidermis (P<0.05). Although LAT1 expression was limited to the basal layer or rim of the nests in KA, LAT1 expression was also observed in the center of the nests in BCC and SCC (P<0.001). Thus, LAT1 is differentially expressed in various skin lesions and may be an especially useful marker to distinguish KA from SCC.
L型氨基酸转运体1(LAT1)是一种不依赖钠离子的中性氨基酸转运体,在细胞增殖中起重要作用。尽管已通过免疫组织化学在各种器官中研究了LAT1在人类致癌过程中的作用,但尚未见LAT1在皮肤中表达的报道。因此,在本研究中,对15例角化棘皮瘤(KA)、10例脂溢性角化病、16例鲍温病、11例基底细胞癌(BCC)、9例鳞状细胞癌(SCC)以及作为对照的61例正常表皮进行了LAT1免疫组织化学检测。结果显示,正常表皮中偶尔可见LAT1表达仅限于基底层,而在脂溢性角化病和鲍温病的上皮中其表达显著降低(P<0.05)。相比之下,KA、BCC和SCC的上皮中LAT1表达率显著高于正常表皮(P<0.05)。虽然KA中LAT1表达仅限于基底层或巢状结构的边缘,但在BCC和SCC的巢状结构中心也观察到LAT1表达(P<0.001)。因此,LAT1在各种皮肤病变中表达存在差异,可能是区分KA和SCC的特别有用的标志物。